ondansetron has been researched along with Anemia in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Anemia: A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, J | 1 |
| Sethi, A | 1 |
| Reyes-Múgica, M | 1 |
| Antaya, R | 1 |
1 other study available for ondansetron and Anemia
| Article | Year |
|---|---|
Life-threatening blood loss from scratching provoked by pruritus in the bulky perineal nevocytoma variant of giant congenital melanocytic nevus in a child.
Topics: Anal Canal; Anemia; Antipruritics; Child, Preschool; Female; Hemorrhage; Humans; Nevus, Pigmented; O | 2005 |